Innovations in Testing for the Detection of Lyme Disease

Each year, some 300,000 people in the United States contract Lyme disease, and according to the CDC, that number is on the rise. Early detection and treatment can help resolve symptoms and prevent the progression of Lyme disease. However, there are still limitations with the current testing modalities that can often take up the valuable time needed for prompt treatment to occur.

Ereka Vetrini and her guest, Raymond Dattwyler, M.D., discuss Lyme disease and a solution for a timelier diagnosis. ZEUS Borrelia Modified Two-Tier algorithms, MTTT-1™ and MTTT-2™, improve early Lyme disease detection by up to 30%. When used in combination, these assays help clinical laboratorians simplify testing processes while reducing turnaround time, thereby helping patients get their results faster.